Document Details
Form
Filing Date
Feb 03, 2021
Document Date
Feb 01, 2021
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
BioXcel Therapeutics
Issuer
BioXcel Therapeutics, Inc.